Objective To investigate the effect of appropriate dosage of remimazolam in combination with remifentanil on stress response and cognitive function in elderly patients gastrointestinal endoscopy.
Methods Elderly patients undergoing gastrointestinal endoscopy in the Department of Anesthesiology and Pain of the First People's Hospital of Yongkang from June 2021 to June 2023 were selected as the study subjects and were divided into group A (0.15 mg·kg-1), group B (0.20 mg·kg-1) and group C (0.25 mg·kg-1) according to the different doses of remimazolam. Modified alertness/sedation (MOAA/S) scores, anesthesia-related indexes (first sedation success, gastrointestinal endoscopy time awakening time, and discharge time), stress-related indexes [cortisol (COR), epinephrine (ADR) and adrenocorticotropic hormone (ACTH)], mini-mental status examination (MMSE) scores and anesthesia-related adverse reactions were compared among the three groups.
Results A total of 186 patients were included in the study, with 62 patients in each group. The MOAA/S scores of groups B and C were significantly lower than those in group A (P<0.05) immediately after gastrointestinal endoscopy, 3 min and 6 min for gastroenteroscopy. The success rate of first sedation in groups B and C was significantly higher than that in group A, while the time of gastrointestinal endoscopy was significantly lower than that in group A, and the time of awakening and leaving the room were significantly longer than those in group A (P<0.05). The levels of COR, ADR and ACTH immediately after gastrointestinal endoscopy in groups B and C were significantly lower than those in group A (P<0.05). The MMSE scores of groups B and C at 10 min and 30 min after wake were significantly higher than those in group A (P<0.05). The total incidence of adverse reactions in group B was significantly lower than that in groups A and C (P<0.05).
Conclusion 0.20 mg·kg-1 and 0.25 mg·kg-1 remimazolam for geriatric gastrointestinal endoscopy have better sedative effect, can reduce the degree of stress response, and have less impact on cognitive function, but the dose of 0.25 mg·kg-1 can lead to an increase in the incidence of hypotension and hypoxemia, and the recommended dose of remimazolam in geriatric gastrointestinal endoscopy is 0.20 mg·kg-1.
1.张珂, 李洪图, 张娜, 等. 阿芬太尼或舒芬太尼复合咪达唑仑与丙泊酚在无痛胃肠镜检查的效果[J]. 临床麻醉学杂志, 2022, 38(11): 1163-1166. [Zhang K, Li HT, Zhang N, et al. Efficacy of afentanil or sufentanil in combination with midazolam and propofol in painless gastroin-testinal endoscopy[J]. Journal of Clinical Anesthesiology, 2022, 38(11): 1163-1166.] DOI: 10.12089/jca.2022.11.008.
2.薛富善, 邹毅, 岳云. 术后认知功能障碍更名及其带来的重大影响[J]. 国际麻醉学与复苏杂志, 2019, 40(6): 513-515. [Xue FS, Zou Y, Yue Y. The renaming of postoperative cognitive dysfunction and its significant impact[J]. International Journal of Anesthesiology and Resuscitation, 2019, 40(6): 513-515.] DOI: 10.3760/cma.j.issn.1673-4378.2019.06.001.
3.Li J, Zhu X, Yang S, et al. Lidocaine attenuates cognitive impairment after isoflurane anesthesia by reducing mitochondrial damage[J]. Neurochem Res, 2019, 44(7): 1703-1714. DOI: 10.1007/s11064-019-02799-0.
4.崔林, 王海霞, 王建松, 等. 丙泊酚复合瑞芬太尼或芬太尼对行无痛胃镜检查的哺乳妇女泌乳功能的影响[J]. 中国性科学, 2020, 29(4): 100-103. [Cui L, Wang HX, Wang JS, et al. Effects of propofol combined with remifentanil or fentanyl on the lactation function in lactating women undergoing painless gastroscopy[J]. Chinese Journal of Human Sexuality, 2020, 29(4): 100-103.] DOI: 10.3969/j.issn.1672-1993.2020.04.029.
5.冯燕春, 黄格, 阮浩神, 等. 瑞芬太尼复合依托咪酯和丙泊酚闭环靶诱导用于合并高血压的全麻气管插管患者效果观察[J]. 山东医药, 2021, 61(22): 54-56. [Feng YC, Huang G, Ruan HS, et al. Efficacy of remifentanil combined with etomidate and propofol for closed loop target induction in patients with general anesthesia combined with hypertension[J]. Shandong Medical Journal, 2021, 61(22): 54-56.] DOI: 10.3969/j.issn.1002-266X.2021.22.013.
6.李富贵, 王皓, 王云, 等. 瑞马唑仑复合阿芬太尼在无痛胃肠镜检查中的应用[J]. 临床麻醉学杂志, 2022, 38(7): 767-769. [Li FG, Wang H, Wang Y, et al. Application of remazolam combined with afentanil in painless gastroenteroscopy[J]. Journal of Clinical Anesthesiology, 2022, 38(7): 767-769.] DOI: 10.12089/jca.2022.07.018.
7.瑞马唑仑临床应用专家指导意见专家组. 瑞马唑仑临床应用专家指导意见[J]. 国际麻醉学与复苏杂志, 2023, 44(6): 561-566. DOI: 10.3760/cma.j.cn321761-20230404-10008.
8.Lera dos Santos ME, Maluf-Filho F, Chaves DM, et al. Deep sedation during gastrointestinal endoscopy: propofol-fentanyl and midazolam-fentanyl regimens[J]. World J Gastroenterol. 2013, 19(22): 3439-3446. DOI: 10.3748/wjg.v19.i22.3439.
9.唐娟娟, 肖军. 蒙特利尔认知评估量表与简易精神状态量表在认知功能障碍筛查中的应用与比较[J]. 实用医院临床杂志, 2011, 8(2): 200-202. [Tang JJ, Xiao J. Application and comparison of montreal cognitive assessment and mini-mental state examination in the screening of cognitive impairment[J]. Practical Journal of Clinical Medicine, 2011, 8(2): 200-202.] DOI: 10.3969/j.issn.1672-6170.2011.02.084.
10.陈烁, 陈佳炜, 黄培良, 等. 瑞芬太尼致麻痹性肠梗阻1例[J]. 中国药师, 2022, 25(6): 1048-1049. [Chen S, Chen JW, Huang PL, et al. Paralytic intestinal obstruction caused by remifentanil: a case report[J]. China Pharmacist, 2022, 25(6): 1048-1049.] DOI: 10.19962/j.cnki.issn1008-049X.2022.06.021.
11.Chernova AP, Shormanov VK, Davydkina AE. Propofol: use, toxicology and assay features[J]. Sud Med Ekspert, 2022, 65(5): 46-51. DOI: 10.17116/sudmed20226505146.
12.万芳, 何旋, 陈鹤祥, 等. 3种静脉麻醉方案对胃镜检查患者心理焦虑及舒适度的影响[J]. 中国药师, 2022, 25(6): 1024-1027. [Wang F, He X, Chen HX, et al. Effects of three intravenous anesthesia schemes on psychological anxiety and comfort of patients under-going gastroscopy[J]. China Pharmacist, 2022, 25(6): 1024-1027.] DOI: 10.19962/j.cnki.issn1008-049X.2022.06.015.
13.梁静, 商燕, 任儒国, 等. 瑞马唑仑复合瑞芬太尼麻醉用于无痛胃镜检查中的安全性及对生命体征的影响[J]. 临床医学研究与实践, 2022, 7(15): 90-94. [Liang J, Shang Y, He RG, et al. Safety of remimazolam combined with remifentanil anesthesia in painless gastroscopy and its effect on vital signs[J]. Clinical Research and Practice, 2022, 7(15): 90-94.] DOI: 10.19347/j.cnki.2096-1413.202215024.
14.肖兴鹏, 杨璐, 田文敏, 等. 瑞马唑仑用于全凭静脉麻醉的有效性及安全性观察[J]. 中国药师, 2022, 25(11): 1976-1979. [Xiao XP, Yang L, Tian WM, et al. Anesthetic effect and safety of remimazolam in total intravenous anesthesia[J]. China Pharmacist, 2022, 25(11): 1976-1979.] DOI: 10.19962/j.cnki.issn1008-049X.2022.11.017.
15.秦菲菲, 廉仲明, 黄亚茹, 等. 复合阿芬太尼时瑞马唑仑抑制双腔支气管插管反应的半数有效剂量[J]. 临床麻醉学杂志, 2023, 39(4): 375-378. [Qin FF, Lian ZM, Huang YR, et al. The median effective dose of remimazolam combined with alfentanil suppressing the response to double-lumen bronchial intubation[J]. Journal of Clinical Anesthesiology, 2023, 39(4): 375-378.] DOI: 10.12089/jca.2023.04.007.
16.彭蕊, 王倩, 杨天爽, 等. 不同剂量瑞马唑仑复合舒芬太尼在无痛胃镜检查术中的比较[J]. 临床麻醉学杂志, 2023, 39(4): 389-392. [Peng R, Wang Q, Yang TS, et al. Comparison of different doses of remimazolam combined with sufentanil in painless gastroscopy[J]. Journal of Clinical Anesthesiology, 2023, 39(4): 389-392.] DOI: 10.12089/jca.2023.04.010.
17.史媛, 蒋毅, 董贝贝, 等. 瑞马唑仑和咪达唑仑对健康老龄大鼠认知功能影响的比较[J]. 中华麻醉学杂志, 2020, 40(9): 1089-1092. [Shi Y, Jiang Y, Dong BB, et al. Comparison of effects of remazolam and midazolam on cognitive function in healthy aged rats[J]. Chinese Journal of Anesthesiology, 2023, 44(6): 561-566] DOI: 10.3760/cma.j.cn131073.20200406.00913.
18.马根山, 陈小红, 曹汉忠. 瑞马唑仑在老年肥胖患者无痛胃镜检查中的应用效果[J]. 临床麻醉学杂志, 2022, 38(10): 1057-1060. [Ma GS, Chen XH, Cao HZ. Effects of remimazolam on the efficacy in elderly obese patients undergoing painless gastroscopy[J]. Journal of Clinical Anesthesiology, 2022, 38(10): 1057-1060.] DOI: 10.12089/jca.2022.10.009.
19.王倩, 王茂华, 杨天爽, 等. 不同剂量瑞马唑仑复合丙泊酚应用于无痛胃镜检查的效果[J]. 临床麻醉学杂志, 2022, 38(2): 163-166. [Wang Q, Wang MH, Yang TS, et al. Effect of different doses of remimazolam combined with propofol in painless gastroscopy[J]. Journal of Clinical Anesthesiology, 2022, 38(2): 163-166.] DOI: 10.12089/jca.2022.02.011.